Home > Current issue > JPPR 2006 > JPPR September 2006

Volume 36, No. 3, September 2006


Developing the Skills and Attributes of a Clinical Pharmacist within a Master of Pharmacy Curriculum
Gabrielle Cooper, 172

Clinical Pharmacy, Formulation for a Better Future?
Patrick A Ball, 172

Clinical Governance
Jo-anne E Brien, 174


A Novel Medicines Management Pathway (members only) 
Jenny D Blennerhassett, Brigitte M Cusack, Carlene D Smith, Louise Green, Kate L Tribe, 175

Preventing Potassium Problems Permanently: Eliminating Concentrated Potassium Chloride Errors (members only) 
Mark Lubliner, Melita Van de Vreede, 181

Experience with Drotrecogin in Two Australian Hospitals (members only) 
Fraser D Mackenzie, Peter I Pillans, David A Cook, Alexander E Dixon, Paul A Kubler, 185

Acceptability of Videoconference Technology for the Delivery of Continuing Education to Rural Pharmacists (members only) 
Kevin P McNamara, 187

Extended Roles for Pharmacists in Warfarin Therapy: Identifying Opportunities for Pharmacist Prescribing (members only) 
Amy Khoo, Beata V Bajorek, 190

Risk and Severity of Akathisia Following Administration of Metoclopramide in the Emergency Department (members only) 
Fiona HP Leow, Jonathan C Knott, Fariza Abu Hassan, David McD Taylor, Ruwangi Udayasiri, 194

Pharmacist Prescribing Activities—an Electronic Survey on the Opinions of Australian Pharmacists (members only) 
Olivia C Kay, Beata V Bajorek, Jo-anne E Brien, 199

Dosing of Key Renally Cleared Drugs in the Elderly—Time to be Wary of the eGFR (members only) 
Gregory W Roberts, 204

Audit of Ticarcillan/Clavulanate Usage in a Large Teaching Hospital (members only) 
Fraser D Mackenzie, Peter I Pillans, Johannes Reinhold, David F Looke, Joanna M Sturtevant, 210

Pharmacy Practice

Taking Pharmacy on Tour in Vanuatu (members only) 
Amanda LC Sanburg, 212

Role for Aspirin after Total Hip Replacement? (members only) 
Esther W Chan, 214

Case Report

Urticarial Skin Reaction Induced by Oral Clonidine (members only) 
Raju Paudel, PV Kishore, Pranaya Mishra, Subish Palaian, Binayak C Dwari, 218

Practice Standards

SHPA Standards of Practice for Hospital Pharmacy Outpatient Services, 220 (members only) 

Medication Safety

Medication Safety Series
Edited by Penny Thornton, 225

Geriatric Therapeutics

Beta-Blockers for Treatment of Heart Failure in the Elderly
Hendrik Zimmet, Henry Krum, 229


Literature summaries of the latest developments in pharmacy practice and therapeutics (members only) 
Edited by Neil Keen, 234

Other Sections

Letters to the Editor, 244

American Society of Consultant Pharmacists Conference—Geriatrics ’06, Lisa Nissen, 244-5
Outcomes of parent education and counselling, Sunil S Mohite, MS Ganachari, 245
Controversies in infectious diseases, Minyon Avent, 245-6  
Adverse drug reaction pattern in hospitalised children of a South Indian teaching hospital, Siddhartha Ghosh, Leelavathy D Acharya, Padma GM Rao, Nidhin Mohan Nair, Subish Palaian, 246
D2, D3—what’s the difference? Cheng S Choo, Zola Maylor, John D Wark, 246-8
Taking the midnight train to Georgia, Ben Stevenson, 248-9
Telepharmacy—another model, the CAPTOS, Judith Longworth, 249

SHPA Research and Development Grants Program, 189, 193, 198
Advertisers’ Index, 219

Article Reprints

Copies of articles from the Journal of Pharmacy Practice and Research and The Australian Journal of Hospital Pharmacy can be ordered from the National Library of Australia. You can order online at the NLA website by providing the citation and credit card details.

Member Login

Forgotten your login details?

Join SHPA.
Buy online courses

  • Update on Medicinal Cannabis
  • As medicinal cannabis products become more accessible and prescribed, hospital pharmacists will need to be cognisant of how these medicines are handled and the federal and jurisdictional requirements they will need to comply with. SHPA is committed to keeping abreast of this emerging therapy, and below is a snapshot on where medicinal cannabis is at presently in Australia.
  • SHPA Will Take Action to Support Continuation of Advanced Practice Recognition
  • The Society of Hospital Pharmacists of Australia (SHPA) CEO, Kristin Michaels, responding to today's announcement by the Australian Pharmacy Council to end the National Credentialing of Advanced Practice Pharmacists, said the Society will continue to strongly support Advanced Practice.
  • SHPA Vision for the Future of Pharmacy is Winning Strong Support
  • Professor Michael Dooley said today the Society has received over 30 applications from hospitals and health services for the SHPA Residency Program inaugural intake commencing in 2017.


    Member Login


    Logging Into SHPA Website.